Technology Licensing

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector
10 Jul 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

5 Jul 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

Latest

View all
2 Jul 2019

Japanese aircon giant latest to pledge patent non-aggression

Ten years ago, the company bet big on sharing technology with Chinese upstarts. Now Daikin is opening up a portfolio of refrigerant patents Read more

1 Jul 2019

Oppo closes first patent acquisition deal with a Chinese university

It is still rare to see major tech businesses in China acquiring rights generated by academic institutions, but given geopolitical and trade realities we may well see more of it in the future Read more

27 Jun 2019

Huawei has reaped $1.4 billion in licence fees since 2015, white paper says

The Chinese company also revealed its royalty outflow – $6 billion since it took its first licence in 2001, 80% of which has gone to US companies Read more

24 Jun 2019

New research highlights importance of US government on patented technologies

Federal support particularly crucial for start-ups with Department of Defense leading the way among state agencies Read more

News

View all
17 Jun 2019

IPBC Global 2019 – Day One highlights

All the big stories from the first full day of the world’s pre-eminent conference about IP value creation Read more

17 Jun 2019

Why it's time for the world of patents to embrace diversity and gender equality

Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens Read more

12 Jun 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century Read more

5 Jun 2019

Inside the rapidly changing global market for patent legal services

In advance of the online publication of the 2019 edition of the IAM Patent 1000, we reveal the key takeaways uncovered during the research process Read more

Analysis

View all
21 Jun 2019

US strategy for state-owned patents under increasing scrutiny amidst drug price controversies

The government is facing calls to better leverage its own IP in the public interest following revelations about PrEP rights Read more

20 Jun 2019

US tells WTO to hit pause on China IP complaint

Suspension of the probe may not herald a broader deal, but it does underscore the significant legislative concessions China has made on tech transfer and other IP issues Read more

19 Jun 2019

Nokia appoints new head of its billion euro licensing business

Jenni Lukander takes over as president of Nokia Technologies as Finnish telco re-shapes its senior leadership team Read more

18 Jun 2019

Below the radar, a changing of the guard at Apple

Long-time chief IP Counsel BJ Watrous quietly left the position at the end of last year to be replaced by former lead patent counsel Read more

Insights

View all
30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Find an expert